Posted by Jon Anderson on Nov 29th, 2024
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Equities researchers at B. Riley issued their FY2024 EPS estimates for Cognition Therapeutics in a research report issued to clients and investors on Tuesday,...
More of this article »